InvestorsHub Logo
Followers 80
Posts 24704
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Friday, 06/23/2017 8:22:09 AM

Friday, June 23, 2017 8:22:09 AM

Post# of 27623
AVEO - .7278 Pre-market now at 1.22/1.23

AVEO Oncology Announces Positive CHMP Opinion for Tivozanib as a Treatment of Advanced Renal Cell Carcinoma



Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.